FN2 Earnings Intelligence
Insmed Incorporated income statement (quarterly)
Insmed Incorporated (INSM) Income Statement (quarterly) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - |
| - Cash | $403.2 | $1,284.3 | $334.8 | $582.2 | $544.8 |
| + Debt | - | - | - | - | - |
| Enterprise Value | - | - | - | - | - |
| Revenue | $92.8 | $107.4 | $142.3 | $306 | $425.5 |
| % Growth | - | - | - | - | - |
| Gross Profit | $71.5 | $79.3 | $113 | $258.5 | $358.3 |
| % Margin | 77.1% | 73.9% | 79.4% | 84.5% | 84.2% |
| EBITDA | -$246.3 | - | - | -$150.4 | - |
| % Margin | -265.3% | - | - | -49.2% | - |
| Net Income | -$256.6 | -$321.7 | -$370 | -$163.6 | -$13.2 |
| % Margin | -276.4% | -299.5% | -260.0% | -53.5% | -3.1% |
| Diluted EPS | -$1.42 | -$1.70 | -$1.75 | -$0.76 | -$0.06 |
| % Growth | - | - | - | - | - |
| Operating Cash Flow | -$262.1 | - | - | -$222.7 | - |
| CapEx | $10.1 | - | - | $3.5 | - |
| Free Cash Flow | -$272.2 | - | - | -$226.2 | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Revenue | $92.8 | $107.4 | $142.3 | $306 | $425.5 |
| Gross Profit | $71.5 | $79.3 | $113 | $258.5 | $358.3 |
| EBITDA | -$246.3 | - | - | -$150.4 | - |
| Net Income | -$256.6 | -$321.7 | -$370 | -$163.6 | -$13.2 |
| Diluted EPS | -$1.42 | -$1.70 | -$1.75 | -$0.76 | -$0.06 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $403.2 | $1,284.3 | $334.8 | $582.2 | $544.8 |
| Short-term Debt | - | - | - | - | - |
| Long-term Debt | $1,105.1 | $538.5 | $539.7 | $542.2 | $543.5 |
| Total Debt | - | - | - | - | - |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$262.1 | - | - | -$222.7 | - |
| Capital Expenditure | $10.1 | - | - | $3.5 | - |
| Free Cash Flow | -$272.2 | - | - | -$226.2 | - |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Revenue Growth | - | - | - | - | - |
| Gross Margin | 77.1% | 73.9% | 79.4% | 84.5% | 84.2% |
| EBITDA Margin | -265.3% | - | - | -49.2% | - |
| Net Margin | -276.4% | -299.5% | -260.0% | -53.5% | -3.1% |
| FCF Margin | -293.2% | - | - | -73.9% | - |
| Diluted EPS Growth | - | - | - | - | - |
Get the INSM recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.